NICU was formally founded in 1983 with the support of Project HOPE from the United States. It is one of the earliest and largest NICUs in China. Currently, it has 4 chief physicians, 5 deputy chief physicians, and 2 doctoral supervisors, with 50 beds. NICU treats more than 1000 critically ill infants annually, including very low birth weight, severe hypoxic-ischemic encephalopathy and brain damage, respiratory failure and lung injury, severe infections and septic shock, refractory arrhythmias, severe metabolic disorders, etc.
NAVA mechanical ventilation technology, ECMO technology, retinopathy screening and laser treatment for premature infants, hypothermia of hypoxic-ischemic encephalopathy, comprehensive treatment of severe hyperbilirubinemia, follow-up and rehabilitation of high-risk infants, comprehensive treatment of pulmonary hypertension, respiratory function testing, invasive measurement of blood pressure, bedside echocardiographic monitoring, and 24-hour dynamic brain function monitoring are well developed for the diagnosis and treatment of children. The survival rate of persistent pulmonary hypertension in newborns is above 90%; the survival rate of very low birth weight infants is above 97%; and the survival rate of extremely low birth weight infants is above 85%; and the lowest weight of surviving premature infant is 562. NICU is equipped with a complete monitoring and rescue transfer system, various non-invasive assisted breathing equipment, regular-frequency and high-frequency ventilators, brain function monitors, mild hypothermia instruments, etc. NICU team is responsible for the emergency transfer of critically ill newborns in the province.
(1)Extremely low birth weight infant;
(2)Severe hypoxic-ischemic encephalopathy and brain damage;
(3)Respiratory failure and lung injury;
(4)Severe infections and septic shock;
(6)Severe water and electrolyte disorders;
(7)Genetic metabolic diseases;
(8)Complex congenital heart diseases;
(9)Birth defects and congenital deformities that require surgery;
(10)Critically ill newborn.
(1) The respiratory support technology is at the leading level in China, and it is the earliest unit to develop high-frequency ventilation and NAVA mechanical ventilation technology, ECMO technology, and NO inhalation to treat persistent pulmonary hypertension in newborns in mainland China;
(2)Enteral and parenteral nutrition support for very low birth weight infants and surgical children is well developed, and the youngest child with short bowel syndrome was successfully treated in China;
(3)Infants with severe hyperbilirubinemia and bilirubin encephalopathy are evaluated the degree of neurological damage and prognosis by using multimodal magnetic resonance imaging;
(4)A follow-up rehabilitation clinic for high-risk infants was set up to carry out long-term follow-up and interventions to further improve patient outcomes.
(1)Besides conducting basic research on neonatal respiratory failure, persistent pulmonary hypertension, and neonatal infections in recent years, a number of new clinical diagnosis and treatment technologies have been developed, and national guidelines for the diagnosis and treatment of neonatal persistent pulmonary hypertension and diseases have been developed;
(2)Based on a national epidemiological survey of hyperbilirubinemia, preliminary guidelines for jaundice intervention in China were formulated;
(3)The stabilization of critically ill newborns was promoted in the whole country by NICU team;
(4)The technology patent for early diagnosis of neonatal infection was obtained, and a number of national multi-center clinical studies were organized, and special reports at international conferences were made;
(5)The long-term academic exchanges, talent training and scientific research cooperation with internationally renowned children's hospitals have been deepened over the years. Several national continuing education programs are held, attracting NICU professionals all over the country to attend the program for further study; and more than 30 scientific research projects were conducted and over 200 high-quality papers were published, including more than 80 SCI papers. NICU is an overseas training rotation base for the attending doctors of NICU of Loma Linda University Children' s Hospital.